A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer.

Saved in:

Bibliographic Details
Title:	A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer.
Authors:	Pandit-Taskar, Neeta^1,2, O'Donoghue, Joseph A.³, Chetty, Dushen⁴, Max, Steven⁴, Wanik, Danielle⁵, Ilovich, Ohad⁵, Russell, Michael⁴, Nyima, Tenzin⁶, Divgi, Chaitanya R.⁴, Yu, Margaret⁴, Morris, Michael J.^7,8 morrism@mskcc.org
Source:	Journal of Nuclear Medicine. Jul2024, Vol. 65 Issue 7, p1051-1056. 6p.
Database:	Engineering Source

Description
ISSN:	01615505
DOI:	10.2967/jnumed.124.267416